[1] EDWARDS A,QI S,LIU F,et al.Rationalising polymer selection for supersaturated film forming systems produced by an aerosol spray for the transdermal delivery of methylphenidate[J].Eur J Pharm Biopharm,2017,114:164-174.
[2] 姚亮宇,梁秉文.外用制剂是儿童新药研发的首选[J].中医外治杂志,2017,26(2):48-49.
[3] EVREN A Y,?ZGE .Transdermal spray in hormone delivery[J].Trop J Pharm Res,2014,13(3):469-474.
[4] 陈欣欣,符绩雄,黄健.祛敏通鼻喷膜剂治疗常年性变应性鼻炎临床观察[J].中国中西医结合杂志,2011,31(5):643-646.
[5] 樊荣丹,陈鹰,张樱子,等.复方消伤痛喷膜剂的制备与质量控制[J].中国药师,2014,17(5):779-781.
[6] 高倩.黄马缓释喷膜剂的研制[D].重庆:重庆医科大学,2016.
[7] 俞振伟,梁漪,梁文权.雌二醇透皮喷雾成膜剂的研制及其体外评价[J].药学学报,2013,48(5):746-751
[8] 崔曰新.盐酸利多卡因喷膜剂的制备[D].广州:广东药科大学,2016.
[9] 余磊,李银保,张剑.水溶性聚乙烯醇在药物缓释中应用进展[J].赣南医学院学报,2016,36(6):975-979.
[10] PERFETTI G,ALPHAZAN T,VAN HP,et al.Relation between surface roughness of free films and process parameters in spray coating[J].Eur J Pharm Sci,2011,42(3):262-272.
[11] 高丽娜.盐酸贝那普利口腔膜剂的制备及质量控制[D].杨凌:西北农林科技大学,2016.
[12] LEE S,JUNG I,YU S,et al.Effect of recombinant human epidermal growth factor impregnated wchitosan film on hemostasis and healing of blood vessels[J].Arch Plast Surg,2014,41(5):466-471.
[13] ASHLEIGH C,RACHAEL O,HONGYAN M,et al.Chitosan-based scabrousness membranes for antibacterial filter applications[J].Carbohydr Polym,2013,92(1):254-259.
[14] RANADE S,BAJAJ A,LONDHE V,et al.Fabrication of topical metered dose film forming sprays for pain management[J].Eur J Pharm Sci,2017,100:132-141.
[15] 吕定刚.中药经皮给药促渗作用的研究概况[J].北方药学,2014,11(5):65-66.
[16] 王曙东,刘文雅,王争,等.不同促渗剂对复方红茴香喷雾剂体外透皮吸收的影响[J].南京中医药大学学报,2015,31(1):84-86.
[17] 谢宇,王健鹏.一种壳聚糖纳米微粒喷膜剂的制备方法:104922053A[P].2015-09-23.
[18] 刘中伟,焦念强,曹廷锋.一种用于轻中度烧烫伤的海洋生物喷膜及其制备方法:106491567A[P].2017-03-15.
[19] MORI N M,PATEL P,SHETH N R,et al.Fabrication and characterization of film-forming voriconazole transdermal spray for the treatment of fungal infection[J].Bulletin Faculty Pharmacy,Cairo University,2017,55(1):41-51.
[20] 张世川,国大亮,刘岩,等.喷膜剂制备工艺与质量控制研究进展[J].药物评价研究,2015,38(4):435-438.
[21] 张清民,翟锡斌,谢汉凤,等.一种伤口消毒喷膜剂及其制备方法:106361816A[P].2017-02-01.
[22] 朱玉莲.化瘀消肿喷膜剂的研究[D].重庆:重庆医科大学,2016.
[23] GARVIE-COOK H,FREDERIKSEN K,PETERSSON K,et al.Characterization of topical film-forming systems using atomic force microscopy and Raman microspectroscopy[J].Mol Pharm,2015,12(3):751-757.
[24] 梁泽鑫,柯军,刘淋蕊,等.pH值对壳聚糖创伤敷料抑菌性能影响探讨[J].中国医疗器械信息,2016,22(17):57-59.
[25] BAKSHI A,BAJAJ A,MALHOTRA G,et al.A novel metered dose transdermal spray formulation for Oxybutynin[J].Indian J Pharm Sci,2008,70(6):733-739.
[26] MENNINI N,CIRRI M,MAESTRELLI F,et al.Comparison of liposomal and NLC(nanostructured lipid carrier)formulations for improving the transdermal delivery of oxaprozin:effect of cyclodextrin complexation[J].Int J Pharm,2016,515(1/2):684-691.
[27] 陈华兵.促进药物透皮和皮肤靶向的纳米载药系统研究[D].武汉:华中科技大学,2008.
[28] 陈桐楷.氢溴酸高乌甲素固体脂质纳米粒作为经皮给药载体的研究[D].广州:广东药学院,2010.
[29] 张静思.超饱和系统促进水杨酸经皮给药的研究[D].天津:天津大学,2013.
[30] 胡涛,朱华旭,郭立玮,等.快速膜乳化与喷雾干燥联用制备汉防己甲素纳米复合粒子及其表征[J].药学学报,2014,49(11):1607-1613.
[31] JENSEN K T,LARSEN F H,CORNETT C,et al.Formation mechanism of coamorphousdrug-amino acid mixtures[J].Mol Pharm,2015,12(7):2484-2492.
[32] L?BMANN K,GROHGANZ H,LAITINEN R,et al.Amino acids as co-amorphous stabilizers for poorly water soluble drugs:Part 1.preparation,stability and dissolution enhancement[J].Eur J Pharm Biopharm,2013,85:873-881.
[33] RAI V,RAGHAVAN L.Transdermal drug delivery systems using supersaturation[M].Berlin Heidelberg:Springer-Verlag,2015:151-161.
[34] PATEL D,KUMAR P,THAKKAR H P.Lopinavir metered-dose transdermal spray through microporatedskin:Permeation enhancement to achieve therapeutic needs[J].J Drug Deliv Sci Technol,2015,29:173-180.
[35] KRISTIINA K,MIRJA P,OSSI K,et al.Systematic evaluation of a spraying method for preparing thin Eudragit-drug films by design of experiments[J].J Drug Deli Sci Technol,2016,35:241-251.
[36] LOPEZ-PINTO J M,GONZALEZ-RODRIGUEZ M L,RABASCO A M.Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes[J].Int J Pharm,2005,298(1):1-12.
[37] YANG X,ZHAO L,ALMASY L,et al.Preparation and characterization of 4-dedimethylamino sancycline(CMT-3)loaded nanostructured lipid carrier(CMT-3/NLC)formulations[J].Int J Pharm,2013,450(1/2):225-234.
[38] 王蕾蕾.黄体酮脂质纳米粒的制备及其生物利用度研究[D].杭州:浙江大学,2007.
[39] SCHWARZ J C,BAISAENG N,HOPPEL M,et al.Ultra-small NLC for improved dermal delivery of coenyzme Q10[J].Int J Pharm,2013,447(1/2):213-217.
[40] U.S.Food and Drug Administration.Center for drug evaluation and research[EB/OL].[2018-01-23].https://google2.fda.gov/search?q=AXIRON+&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&requiredfields=-archive%3AYes&output=xml_no_dtd&getfields=*.
[41] KEHR W.Platform technology.Germany:Epinamics GmbH[EB/OL].[2018-01-23].http://www.epinamics.com/platform-technology/.
[42] 欧斯健,朱小凤,何坦,等.双柏喷膜剂塑料包材吸附性研究[J].中草药,2013,44(18):2537-2541.
[43] 刘维海,常青.皮肤病外用药处方分析及合理用药研究[J].中国药业,2016,25(18):80-82.
[44] 朱小凤.双柏喷膜剂药学研究[D].广州:广州中医药大学,2012.
[45] 王霞蓉,王毅,程翼宇,等.中药单体成分局部给药及其促进吸收方法的研究进展[J].中国药科大学学报,2016,47(3):368-376.
[46] AHMED T A,EL-SAY K M.Transdermal film-loaded finasteride microplates to enhance drug skin permeation:two-step optimization study[J].Eur J Pharm Sci,2016,88:246-256.
[47] YANG S,WU F,LIU J,et al.Phase-transition microneedlepatches for efficient and accurate transdermal delivery of insulin[J].Adv Funct Mater,2015,25(29):4633-4641.